Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Treatment of high-risk patients with diabetes: motivation and teaching intervention: a randomized, prospective 8-year follow-up study.
Rachmani R, Slavacheski I, Berla M, Frommer-Shapira R, Ravid M. Rachmani R, et al. J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S22-6. doi: 10.1681/asn.2004110965. J Am Soc Nephrol. 2005. PMID: 15938028 Free article. Clinical Trial.
Use of a mild sedative helps to identify true non-dippers by ABPM: a study in patients with diabetes mellitus and hypertension.
Rachmani R, Shenhav G, Slavachevsky I, Levy Z, Ravid M. Rachmani R, et al. Blood Press Monit. 2004 Apr;9(2):65-9. doi: 10.1097/00126097-200404000-00002. Blood Press Monit. 2004. PMID: 15096902 Clinical Trial.
Low-dose interferon-alpha accelerates atherosclerosis in an LDL receptor-deficient mouse model.
Levy Z, Rachmani R, Trestman S, Dvir A, Shaish A, Ravid M, Harats D. Levy Z, et al. Among authors: rachmani r. Eur J Intern Med. 2003 Dec;14(8):479-483. doi: 10.1016/j.ejim.2003.08.010. Eur J Intern Med. 2003. PMID: 14962699
Losartan and lercanidipine attenuate low-density lipoprotein oxidation in patients with hypertension and type 2 diabetes mellitus: a randomized, prospective crossover study.
Rachmani R, Levi Z, Zadok BS, Ravid M. Rachmani R, et al. Clin Pharmacol Ther. 2002 Sep;72(3):302-7. doi: 10.1067/mcp.2002.127110. Clin Pharmacol Ther. 2002. PMID: 12235451 Clinical Trial.
Teaching and motivating patients to control their risk factors retards progression of cardiovascular as well as microvascular sequelae of Type 2 diabetes mellitus- a randomized prospective 8 years follow-up study.
Rachmani R, Slavachevski I, Berla M, Frommer-Shapira R, Ravid M. Rachmani R, et al. Diabet Med. 2005 Apr;22(4):410-4. doi: 10.1111/j.1464-5491.2005.01428.x. Diabet Med. 2005. PMID: 15787665 Clinical Trial.
Risk factors for nephropathy in type 2 diabetes mellitus.
Rachmani R, Ravid M. Rachmani R, et al. Compr Ther. 1999 Jun-Jul;25(6-7):366-9. doi: 10.1007/BF02944283. Compr Ther. 1999. PMID: 10470521
Teaching patients to monitor their risk factors retards the progression of vascular complications in high-risk patients with Type 2 diabetes mellitus--a randomized prospective study.
Rachmani R, Levi Z, Slavachevski I, Avin M, Ravid M. Rachmani R, et al. Diabet Med. 2002 May;19(5):385-92. doi: 10.1046/j.1464-5491.2002.00701.x. Diabet Med. 2002. PMID: 12027926 Clinical Trial.
Therapeutic strategies in NIDDM an update.
Ravid M, Rachmani R. Ravid M, et al. Pol Arch Med Wewn. 1997;97 Spec No:56-9. Pol Arch Med Wewn. 1997. PMID: 9275756 Review. No abstract available.
41 results
Jump to page
Feedback